FFA
WST icon

Farther Finance Advisors’s West Pharmaceutical WST Stock Holding History

Farther Finance Advisors’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$268K Sell
722
-290
-29% -$102K ﹤0.01% 2063
2026
Q2 		$363K Buy
1,012
+404
+66% +$124K ﹤0.01% 1796
2026
Q1 		$154K Sell
608
-151
-20% -$37.6K ﹤0.01% 2208
2025
Q4 		$209K Buy
759
+106
+16% +$29K ﹤0.01% 1891
2025
Q3 		$171K Sell
653
-8
-1% -$1.94K ﹤0.01% 1699
2025
Q2 		$145K Sell
661
-103
-13% -$22K ﹤0.01% 1563
2025
Q1 		$168K Sell
764
-214
-22% -$59K ﹤0.01% 1296
2024
Q4 		$320K Buy
978
+54
+6% +$17K 0.01% 780
2024
Q3 		$278K Sell
924
-635
-41% -$194K 0.01% 862
2024
Q2 		$506K Buy
1,559
+1,163
+294% +$411K 0.02% 478
2024
Q1 		$157K Buy
396
+90
+29% +$33.3K 0.01% 777
2023
Q4 		$108K Buy
306
+71
+30% +$25.1K 0.01% 779
2023
Q3 		$88.2K Buy
235
+8
+4% +$3.09K 0.01% 604
2023
Q2 		$86.8K Buy
227
+50
+28% +$17.9K 0.02% 504
2023
Q1 		$61.3K Sell
177
-18
-9% -$5.26K 0.02% 547
2022
Q4 		$45.9K Buy
+195
New +$46.2K 0.02% 511

Other funds holding WST

BTCPP
Border to Coast Pensions Partnership Leeds, United Kingdom $7.27B AUM 24.98% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
AC
Apella Capital West Hartford, Connecticut $7.88B AUM 10.78% 1-Year Est. Return
BRCM
Bright Rock Capital Management Hanover, Massachusetts $529M AUM 8.66% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
WPC
Wedmont Private Capital West Chester, Pennsylvania $4.18B AUM 18.65% 1-Year Est. Return
RT
Rockland Trust Hanover, Massachusetts $2.61B AUM 14.26% 1-Year Est. Return
CPBTD
Central Pacific Bank - Trust Division Honolulu, Hawaii $952M AUM 25.15% 1-Year Est. Return
BWM
Biltmore Wealth Management Tempe, Arizona $323M AUM 13.82% 1-Year Est. Return
RFA
RTD Financial Advisors Philadelphia, Pennsylvania $914M AUM 11.18% 1-Year Est. Return

Farther Finance Advisors's WST Position: Q3 2026 in Review

Farther Finance Advisors reduced its West Pharmaceutical (WST) stake by 29% in Q3 2026, selling an estimated $102K and leaving 722 shares worth $268K. The position accounts for ﹤0.01% of the portfolio, ranked #2063.

Farther Finance Advisors first reported a position in WST in Q4 2022 and has held it in 16 quarters since. The position peaked at $506K in Q2 2024. 29 funds tracked by Wall St. Rank hold WST as of Q3 2026.

  • Farther Finance Advisors held 722 shares of West Pharmaceutical worth $268K as of Q3 2026.
  • Farther Finance Advisors sold 290 West Pharmaceutical shares in Q3 2026, an estimated $102K.
  • West Pharmaceutical made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #2063 holding.
  • Farther Finance Advisors first reported a position in West Pharmaceutical in Q4 2022 and has held it in 16 quarters since.
  • Farther Finance Advisors's West Pharmaceutical position peaked at $506K in Q2 2024.
  • 29 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.